Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis.
Novy C, Busk ØL, Tysnes OB, Landa SS, Aanjesen TN, Alstadhaug KB, Bjerknes TL, Bjørnå IK, Bråthen G, Dahl E, Demic N, Fahlström M, Flemmen HØ, Hallerstig E, HogenEsch I, Kampman MT, Kleveland G, Kvernmo HB, Ljøstad U, Maniaol A, Morsund AH, Nakken O, Olsen CG, Schlüter K, Utvik MS, Yaseen R, Holla ØL, Holmøy T, Høyer H. Novy C, et al. Among authors: morsund ah. Brain Commun. 2024 Mar 14;6(2):fcae087. doi: 10.1093/braincomms/fcae087. eCollection 2024. Brain Commun. 2024. PMID: 38585669 Free PMC article.
Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.
Olsen CG, Busk ØL, Aanjesen TN, Alstadhaug KB, Bjørnå IK, Braathen GJ, Breivik KL, Demic N, Flemmen HØ, Hallerstig E, HogenEsch I, Holla ØL, Jøntvedt AB, Kampman MT, Kleveland G, Kvernmo HB, Ljøstad U, Maniaol A, Morsund ÅH, Nakken O, Novy C, Rekand T, Schlüter K, Schüler S, Tveten K, Tysnes OB, Holmøy T, Høyer H. Olsen CG, et al. Among authors: morsund ah. Neuroepidemiology. 2022;56(4):271-282. doi: 10.1159/000525091. Epub 2022 May 16. Neuroepidemiology. 2022. PMID: 35576897 Free article.
Factors influencing employment after minor stroke and NSTEMI.
Morsund ÅH, Ellekjær H, Gramstad A, Reiestad MT, Midgard R, Sando SB, Jonsbu E, Næss H. Morsund ÅH, et al. J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105036. doi: 10.1016/j.jstrokecerebrovasdis.2020.105036. Epub 2020 Jun 23. J Stroke Cerebrovasc Dis. 2020. PMID: 32807448
Stroke risk after transient ischemic attack in a Norwegian prospective cohort.
Ildstad F, Ellekjær H, Wethal T, Lydersen S, Sund JK, Fjærtoft H, Schüler S, Horn JW, Bråthen G, Midtsæther AG, Morsund ÅH, Lillebø ML, Seljeseth YM, Indredavik B. Ildstad F, et al. Among authors: morsund ah. BMC Neurol. 2019 Jan 3;19(1):2. doi: 10.1186/s12883-018-1225-y. BMC Neurol. 2019. PMID: 30606138 Free PMC article.
Vorapaxar in the secondary prevention of atherothrombotic events.
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators. Morrow DA, et al. N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24. N Engl J Med. 2012. PMID: 22443427 Free article. Clinical Trial.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
Sorensen PS, Lycke J, Erälinna JP, Edland A, Wu X, Frederiksen JL, Oturai A, Malmeström C, Stenager E, Sellebjerg F, Sondergaard HB; SIMCOMBIN study investigators. Sorensen PS, et al. Lancet Neurol. 2011 Aug;10(8):691-701. doi: 10.1016/S1474-4422(11)70144-2. Lancet Neurol. 2011. PMID: 21742556 Clinical Trial.
Thrombolytic therapy in acute ischaemic stroke.
Thomassen L, Waje-Andreassen U, Morsund AH, Hordnes J, Maintz C, Smievoll AI, Russell D. Thomassen L, et al. Among authors: morsund ah. Cerebrovasc Dis. 2002;13(3):163-7. doi: 10.1159/000047770. Cerebrovasc Dis. 2002. PMID: 11914532